Edmond de Rothschild Holding’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,288
| Closed | -$296K | – | 638 |
|
|
2024
Q4 | $296K | Buy |
3,288
+590
| +22% | +$57.2K | 0.01% | 374 |
|
|
2024
Q3 | $267K | Buy |
2,698
+1,078
| +67% | +$106K | ﹤0.01% | 399 |
|
|
2024
Q2 | $150K | Hold |
1,620
| – | – | ﹤0.01% | 456 |
|
|
2024
Q1 | $154K | Hold |
1,620
| – | – | ﹤0.01% | 451 |
|
|
2023
Q4 | $145K | Buy |
1,620
+375
| +30% | +$27.8K | ﹤0.01% | 465 |
|
|
2023
Q3 | $90.9K | Hold |
1,245
| – | – | ﹤0.01% | 498 |
|
|
2023
Q2 | $104K | Sell |
1,245
-135
| -10% | -$11.3K | ﹤0.01% | 497 |
|
|
2023
Q1 | $105K | Buy |
+1,380
| New | +$115K | ﹤0.01% | 507 |
|
|
2022
Q3 | – | Sell |
-17,000
| Closed | -$1.26M | – | 868 |
|
|
2022
Q2 | $1.26M | Hold |
17,000
| – | – | 0.03% | 317 |
|
|
2022
Q1 | $1.53M | Buy |
+17,000
| New | +$1.57M | 0.03% | 299 |
|
|
2021
Q3 | – | Sell |
-2,759
| Closed | -$374K | – | 868 |
|
|
2021
Q2 | $374K | Hold |
2,759
| – | – | 0.01% | 463 |
|
|
2021
Q1 | $374K | Buy |
2,759
+940
| +52% | +$141K | 0.01% | 412 |
|
|
2020
Q4 | $256K | Buy |
1,819
+113
| +7% | +$14.5K | 0.01% | 413 |
|
|
2020
Q3 | $190K | Buy |
1,706
+112
| +7% | +$12.6K | 0.01% | 405 |
|
|
2020
Q2 | $178K | Sell |
1,594
-1,535
| -49% | -$151K | 0.01% | 387 |
|
|
2020
Q1 | $242K | Hold |
3,129
| – | – | 0.01% | 322 |
|
|
2019
Q4 | $298K | Hold |
3,129
| – | – | 0.01% | 337 |
|
|
2019
Q3 | $239K | Hold |
3,129
| – | – | 0.01% | 358 |
|
|
2019
Q2 | $275K | Buy |
3,129
+300
| +11% | +$25.6K | 0.01% | 348 |
|
|
2019
Q1 | $256K | Buy |
2,829
+835
| +42% | +$71K | 0.01% | 350 |
|
|
2018
Q4 | $143K | Sell |
1,994
-2,820
| -59% | -$227K | 0.01% | 430 |
|
|
2018
Q3 | $462K | Buy |
4,814
+2,820
| +141% | +$273K | 0.01% | 344 |
|
|
2018
Q2 | $190K | Hold |
1,994
| – | – | 0.01% | 486 |
|
|
2018
Q1 | $175K | Buy |
1,994
+400
| +25% | +$36.5K | 0.01% | 490 |
|
|
2017
Q4 | $135K | Sell |
1,594
-7,006
| -81% | -$587K | ﹤0.01% | 544 |
|
|
2017
Q3 | $745K | Buy |
8,600
+734
| +9% | +$58.8K | 0.02% | 314 |
|
|
2017
Q2 | $607K | Buy |
7,866
+1,223
| +18% | +$86.7K | 0.02% | 345 |
|
|
2017
Q1 | $461K | Buy |
6,643
+2,143
| +48% | +$144K | 0.01% | 390 |
|
|
2016
Q4 | $266K | Hold |
4,500
| – | – | 0.01% | 454 |
|
|
2016
Q3 | $298K | Hold |
4,500
| – | – | 0.01% | 461 |
|
|
2016
Q2 | $243K | Buy |
+4,500
| New | +$247K | 0.01% | 474 |
|
Other funds holding XBI
Edmond de Rothschild Holding's XBI Position: Q1 2025 in Review
Edmond de Rothschild Holding sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 3,288 shares — an estimated $296K sold.
Edmond de Rothschild Holding first reported a position in XBI in Q2 2016 and held it in 31 quarters. The position peaked at $1.53M in Q1 2022. 685 funds tracked by Wall St. Rank hold XBI as of Q1 2025.
- Edmond de Rothschild Holding reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
- Edmond de Rothschild Holding sold 3,288 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $296K.
- Edmond de Rothschild Holding first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and held it in 31 quarters.
- Edmond de Rothschild Holding's State Street SPDR S&P Biotech ETF position peaked at $1.53M in Q1 2022.
- 685 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.
Based on Edmond de Rothschild Holding's 13F filing for Q1 2025, filed 15 May 2025.